Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans
- PMID: 18178692
- DOI: 10.1136/ard.2007.081604
Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans
Abstract
Objective: To better understand the impact of gout on functional status, health-related quality of life (HRQoL), mortality and healthcare utilisation in US veterans.
Methods: All veterans seen in Veterans Integrated Service Network-13 from 1 October 1996 to 31 March 1998 received mailed surveys asking about demographic characteristics; performance of activities of daily living and HRQoL by Short Form-36 (SF-36) for Veterans. Administrative data included demographics; inpatient/outpatient healthcare utilisation; ICD-9 codes for gout, medical comorbidities and arthritis excluding gout-"arthritic comorbidity" and 1-year mortality. Multivariable estimates compared results between veterans with/without gout using least means squared.
Subjects: with gout were significantly older, retired, not married, current non-smokers, with more comorbidities. Multivariable-adjusted bodily pain was somewhat worse (49.7 vs 47.1, p<0.01) and mental health (66.7 vs 68.6, p<0.01) domain scores somewhat better in patients with gout, both differences significant but not clinically meaningful (less than threshold of 5-10 points); other SF-36 domain and summary scores and functional limitations were similar. Medical or arthritic comorbidities predicted clinically/statistically lower adjusted scores in all SF-36 domains and physical domains (physical component summary), respectively. Patients with gout had significantly more annual primary care visits (3.5 vs 2.7, p<0.001) and admissions to hospital (18.3% vs 15.1%, p<0.01), fewer mental health visits (10.1% vs 13.7%, p<0.01) and similar mortality (2.6% vs 2.2%, p = 0.23).
Conclusions: Gout is independently associated with higher medical and arthritic comorbidity, primary care and inpatient utilisation. Poorer HRQoL, functional limitation and higher mortality noted in univariate analyses in patients with gout were attributable to higher comorbidity and sociodemographic characteristics.
Similar articles
-
Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study.Semin Arthritis Rheum. 2005 Apr;34(5):755-65. doi: 10.1016/j.semarthrit.2004.08.001. Semin Arthritis Rheum. 2005. PMID: 15846592
-
Spondyloarthritis is associated with poor function and physical health-related quality of life.J Rheumatol. 2009 May;36(5):1012-20. doi: 10.3899/jrheum.081015. Epub 2009 Apr 15. J Rheumatol. 2009. PMID: 19369461 Free PMC article.
-
Racial differences in health-related quality of life and functional ability in patients with gout.Rheumatology (Oxford). 2017 Jan;56(1):103-112. doi: 10.1093/rheumatology/kew356. Epub 2016 Oct 25. Rheumatology (Oxford). 2017. PMID: 28028159 Free PMC article.
-
Gender and use of care: planning for tomorrow's Veterans Health Administration.J Womens Health (Larchmt). 2007 Oct;16(8):1188-99. doi: 10.1089/jwh.2006.0205. J Womens Health (Larchmt). 2007. PMID: 17937572 Review.
-
One year in review 2018: gout.Clin Exp Rheumatol. 2019 Jan-Feb;37(1):1-11. Epub 2018 Dec 21. Clin Exp Rheumatol. 2019. PMID: 30620275 Review.
Cited by
-
Racial and gender disparities among patients with gout.Curr Rheumatol Rep. 2013 Feb;15(2):307. doi: 10.1007/s11926-012-0307-x. Curr Rheumatol Rep. 2013. PMID: 23315156 Free PMC article. Review.
-
Reliability and Validity of the Korean Version of the Gout Impact Scale.J Korean Med Sci. 2023 Sep 4;38(35):e266. doi: 10.3346/jkms.2023.38.e266. J Korean Med Sci. 2023. PMID: 37667577 Free PMC article.
-
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Administration of Verinurad and Febuxostat in Healthy Male Volunteers.Clin Pharmacol Drug Dev. 2019 Feb;8(2):179-187. doi: 10.1002/cpdd.463. Epub 2018 Apr 24. Clin Pharmacol Drug Dev. 2019. PMID: 29688628 Free PMC article. Clinical Trial.
-
Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study.Rheumatol Int. 2017 Feb;37(2):313-322. doi: 10.1007/s00296-016-3634-9. Epub 2016 Dec 21. Rheumatol Int. 2017. PMID: 28004164
-
Oral Treatment With an Engineered Uricase, ALLN-346, Reduces Hyperuricemia, and Uricosuria in Urate Oxidase-Deficient Mice.Front Med (Lausanne). 2020 Nov 24;7:569215. doi: 10.3389/fmed.2020.569215. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33330529 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical